Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Hematology, Transfusion and Cell Therapy
IMPACT OF THE COVID-19 PANDEMIC ON CHEMOTHERAPY/RADIOTHERAPY BURDEN FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA IN BRAZIL, 2017-2023
ICG Moura, V Goularte, L Galhardo, MC Evangelista, R Pereira
10.1016/j.htct.2024.09.572
Hematol Transfus Cell Ther. 2024;46 Supl 4:S341
Full text access
POTENTE REATIVAÇÃO DA PRODUÇÃO DE HEMOGLOBINA FETAL POR NOVO INIBIDOR SELETIVO DE HISTONA DEACETILASE 1 E 2
VGF Pastre, AR Pavan, C Lanaro, DM Albuquerque, RC Chelucci, LLG Ferreira, AD Andricopulo, JLD Santos, FF Costa
10.1016/j.htct.2024.09.064
Hematol Transfus Cell Ther. 2024;46 Supl 4:S39
Full text access
TRATAMENTO DE LINFOMA DIFUSO DE GRANDES CÉLULAS B RECAÍDO/REFRATÁRIO APÓS 2 LINHAS DE TRATAMENTO EM PACIENTE IDOSO E COM OSTEOMIELITE: RELATO DE CASO
VRH Nunes, JTPR Sampaio, RB Leonel, GDC Spelta, RR Lima, GBG Oliveira, AL Sipolatti, GH Silveira
10.1016/j.htct.2024.09.512
Hematol Transfus Cell Ther. 2024;46 Supl 4:S305-6
Full text access
ENVOLVIMENTO DE DOENÇAS LINFOPROLIFERATIVAS CONCOMITANTE A PROLIFERAÇÃO DE IMUNOFENÓTIPO DE LEUCEMIA LINFOCÍTICA CRÔNICA: 2 RELATOS DE CASO RAROS.
JA Balthazar, HVS Chaves, LM Brandão, JS Filho, T Fischer, T Silveira
10.1016/j.htct.2024.09.546
Hematol Transfus Cell Ther. 2024;46 Supl 4:S326
Full text access
Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia
Arthur Gomes Oliveira Braga, Katia Borgia Barbosa Pagnano, Marina Dal'Bó Pelegrini Campioni, Ana Beatriz Pascoal Lopes, Gislaine Oliveira Duarte, Konradin Metze, Irene Lorand-Metze
10.1016/j.htct.2023.06.001
Hematol Transfus Cell Ther. 2024;46:268-72
Full text access
Oligosymptomatic infection by SARS-Cov-2 in catastrophic antiphospholipid syndrome, a singular coincidence: a case report in an Ecuadorian hospital
Jorge Luis Vélez-Páez, Jhonny Manuel Carranza-Jara, Doryz Catalina Almeida-Posso, Steven S. Witkin, Cesar de Almeida-Neto
10.1016/j.htct.2023.06.002
Hematol Transfus Cell Ther. 2024;46:316-20
Full text access
2 - Anuncio Acreditacao
10.1016/S2531-1379(24)00217-7
Hematol Transfus Cell Ther. 2024;46 Supl 1:v
Full text access
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality –cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)
Marcia Garnica, Edvan De Queiroz Crusoe, Glaciano Ribeiro, Rosane Bittencourt, Roberto José Pessoa Magalhães, Karla Richter Zanella, Abrahão Elias Hallack Neto, Juliana Souza Lima, Caroline Bonamin Solo, Emmanuella Graciott Souza, Andre Magalhaes Fernandes, Angelo Maiolino, Vania Hungria
10.1016/j.htct.2023.08.002
Hematol Transfus Cell Ther. 2024;46:153-60
Full text access
Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity
Bárbara Gomes Barion, Tania Rubia Flores da Rocha, Yeh-Li Ho, Bruna de Moraes Mazetto Fonseca, Erica Okazaki, Cynthia Rothschild, Bianca Stefanello, Vanderson Geraldo Rocha, Paula Ribeiro Villaça, Fernanda A. Orsi
10.1016/j.htct.2023.12.003
Hematol Transfus Cell Ther. 2024;46:176-85
Full text access
DOES PET/CT WITH 18F-FLUOROESTRADIOL (18F-FES) CONTRIBUTE TO THE ASSESSMENT OF BREAST CANCER COMPARED TO FLUORINE-2-D-DEOXYGLUCOSE (18F-FDG)?
Bruno Russiano de Oliveira Boeno, Yuri Aguillera Pedreira, Marcelo Moreira da Silva, Carla Lima Santos Viviani, Leonardo Fonseca Monteiro do Prado
10.1016/j.htct.2024.04.078
Hematol Transfus Cell Ther. 2024;46 Supl 2:S18-9
Full text access
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.